Simplex Trading
CCCC icon

Simplex Trading’s C4 Therapeutics CCCC Stock Holding History

Simplex Trading’s Portfolio CCCC Stock Details CCCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$77.6K Buy
29,500
+23,600
+400% +$55.6K ﹤0.01% 5373
2025
Q4 		$11.3K Sell
5,900
-23,600
-80% -$55.9K ﹤0.01% 6914
2025
Q3 		$65K Buy
29,500
+6,000
+26% +$14.4K ﹤0.01% 6179
2025
Q2 		$33K Buy
23,500
+200
+0.9% +$291 ﹤0.01% 6306
2025
Q1 		$37K Buy
23,300
+22,700
+3,783% +$67.7K ﹤0.01% 6065
2024
Q4 		$2K Sell
600
-77,200
-99% -$384K ﹤0.01% 7976
2024
Q3 		$443K Sell
77,800
-5,500
-7% -$33.1K ﹤0.01% 3721
2024
Q2 		$384K Buy
83,300
+51,600
+163% +$308K ﹤0.01% 3940
2024
Q1 		$258K Sell
31,700
-61,300
-66% -$475K ﹤0.01% 4570
2023
Q4 		$525K Buy
93,000
+91,100
+4,795% +$208K ﹤0.01% 3650
2023
Q3 		$3K Sell
1,900
-17,600
-90% -$53.7K ﹤0.01% 7863
2023
Q2 		$53K Sell
19,500
-3,600
-16% -$11.6K ﹤0.01% 5788
2023
Q1 		$72K Buy
23,100
+22,700
+5,675% +$134K ﹤0.01% 5510
2022
Q4 		$2K Sell
400
-600
-60% -$4.97K ﹤0.01% 8533
2022
Q3 		$8K Buy
1,000
+700
+233% +$7.27K ﹤0.01% 8382
2022
Q2 		$2K Sell
300
-13,200
-98% -$116K ﹤0.01% 9306
2022
Q1 		$327K Buy
13,500
+7,700
+133% +$187K ﹤0.01% 4417
2021
Q4 		$186K Buy
+5,800
New +$229K ﹤0.01% 5305

Other funds holding CCCC

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Simplex Trading's CCCC Position: Q1 2026 in Review

Simplex Trading sold out of C4 Therapeutics (CCCC) in Q1 2026, closing a stake of 30,658 shares — an estimated $72.2K sold.

Simplex Trading first reported a position in CCCC in Q1 2022 and held it in 11 quarters. The position peaked at $903K in Q1 2022. 123 funds tracked by Wall St. Rank hold CCCC as of Q1 2026.

  • Simplex Trading reported no remaining C4 Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 30,658 C4 Therapeutics shares in Q1 2026, an estimated $72.2K.
  • Simplex Trading first reported a position in C4 Therapeutics in Q1 2022 and held it in 11 quarters.
  • Simplex Trading's C4 Therapeutics position peaked at $903K in Q1 2022.
  • 123 funds tracked by Wall St. Rank held C4 Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.